Valuation : Zalicus Inc

Market Cap 7L 6L 6L 6L 10.37L 7.12Cr 10.42L 71.58L 27.95L 3.6Cr 28.02L 27.41L 12Cr P/E 2014
-0.83x
P/E 2015 -1.35x
Enterprise Value -1.59Cr -1.38Cr -1.29Cr -1.18Cr -2.22Cr -152Cr -2.23Cr -15Cr -5.97Cr -77Cr -5.98Cr -5.85Cr -255.03Cr EV / Sales 2014
14,77,02,94,750x
EV / Sales 2015 8,36,58,631x
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.78%-1.42%+2.49%+22.78% 5.05TCr
-6.00%-0.75%+442.41%+544.39% 4.46TCr
-0.24%+0.74%+38.69%+18.02% 4.31TCr
-1.55%-2.07%+23.08%+81.47% 4.17TCr
-0.31%-0.83%+16.15%+51.42% 3.32TCr
-1.79%-3.24%+27.00%+129.56% 1.68TCr
-0.58%-2.12% - - 1.63TCr
-0.88%-0.66%+11.60%+27.75% 1.46TCr
-1.66%-1.25%+78.59%+46.66% 1.39TCr
Average -1.53%-1.06%+80.00%+115.26% 3.05TCr
Weighted average by Cap. -1.70%-1.06%+95.71%+133.63%

Financials

2014 2015
Net sales 0 0 0 0 0.01 0.38 0.01 0.04 0.01 0.19 0.02 0.01 0.64 0.7 0.61 0.57 0.52 0.97 66.86 0.98 6.72 2.63 33.81 2.63 2.57 112.19
Net income -4.18Cr -3.61Cr -3.39Cr -3.09Cr -5.82Cr -399.11Cr -5.84Cr -40Cr -16Cr -201.81Cr -16Cr -15Cr -669.66Cr -5.22Cr -4.51Cr -4.22Cr -3.86Cr -7.25Cr -497.77Cr -7.29Cr -50Cr -20Cr -251.7Cr -20Cr -19Cr -835.21Cr
Net Debt -1.42Cr -1.22Cr -1.15Cr -1.05Cr -1.97Cr -135.25Cr -1.98Cr -14Cr -5.31Cr -68Cr -5.32Cr -5.21Cr -226.93Cr -1.67Cr -1.44Cr -1.35Cr -1.23Cr -2.32Cr -159.11Cr -2.33Cr -16Cr -6.25Cr -80Cr -6.26Cr -6.13Cr -266.98Cr
Logo Zalicus Inc
EPIRUS Biopharmaceuticals Inc is a United States-based company. The Company operates as a pharmaceutical preparation manufacturer.
Employees
-